Frankfurt - Delayed Quote EUR

AbCellera Biologics Inc. (8QQ.F)

Compare
3.3320
+0.1270
+(3.96%)
At close: January 24 at 3:46:42 PM GMT+1

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
BOOTH ANDREW Chief Financial Officer Purchase May 26, 2023 283,959
HANSEN CARL L.G. Chief Executive Officer Conversion of Exercise of derivative security Nov 25, 2024 56,984,000
HAYDEN MICHAEL REUBEN Director Purchase Sep 22, 2023 --
LECAULT VERONIQUE Chief Operating Officer Conversion of Exercise of derivative security Jun 21, 2024 9,613,670
MONTALBANO JOHN S. Director Purchase Nov 8, 2023 91,000
THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security Stock Gift Dec 4, 2024 55,800,000